The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.
How Ozempic Maker Novo Nordisk Lost Its Shine
Related Posts
How the Stock Market Has Done Under Trump
When President Trump entered his first term, stocks were steadily marching upward. This time, the trajectory has inverted.
The Fed Isn’t Rushing to Save the Markets This Time
With stocks in a steep decline and tariffs inducing recession jitters, the patience of investors may be tested.
Truemed, a Start-Up Run by an RFK. Jr. Aide, Gives Tax Breaks for Meat and Mattresses
The start-up, called Truemed, helps people buy meat and mattresses with money that isn’t subject to federal income tax. But…